Lv1
36 积分 2022-03-14 加入
B cells are associated with survival and immunotherapy response in sarcoma
1天前
待确认
The present and future of bispecific antibodies for cancer therapy
17天前
已完结
Trastuzumab rezetecan, a HER2-directed antibody–drug conjugate, in patients with advanced HER2-mutant non-small-cell lung cancer (HORIZON-Lung): phase 2 results from a multicentre, single-arm study
22天前
已完结
New predictors for immunotherapy responses sharpen our view of the tumour microenvironment
26天前
已完结
B cells are associated with survival and immunotherapy response in sarcoma
26天前
已完结
Tertiary lymphoid structures improve immunotherapy and survival in melanoma
26天前
已完结
B cells and tertiary lymphoid structures promote immunotherapy response
26天前
已完结
New predictors for immunotherapy responses sharpen our view of the tumour microenvironment
26天前
已完结
Targeting HER2 heterogeneity in breast and gastrointestinal cancers
28天前
已完结
Dealing with KRAS G12C inhibition in non-small cell lung cancer (NSCLC) – biology, clinical results and future directions
29天前
已完结
皖公网安备34019202002308
